A Phase I Trial of Anti-LAG-3 or Anti-CD137 Alone and in Combination with Anti-PD-1 in Patients with Recurrent GBM

Grant

Date/time Interval

  • June 30, 2016 - June 2, 2019
  • Total Award Amount

  • 12000.00
  • Direct Costs

  • 6180.00
  • Sponsor Award Id

  • Contributor

  • Fathallah-Shaykh M.D., Ph.D., Hassan   Investigator  
  • Han, Xiaosi   Investigator  
  • Nabors M.D., Louis   Principal Investigator